Publications by authors named "B Bystricky"

Claim this Profile
T
The Role of HE4 in the Follow-Up of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer-CEEGOG OX-01 Study.
Jiri Presl, Pavel Havelka, Vit Weinberger, Petra Ovesna, Peter Fekete, Branislav Bystricky

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic cancer - epidemiology, risk factors, nutritional and infl ammatory prognostic and predictive factors.
J Homolová, D Ondruš, M Ondrušová, B Bystrický, F Kohútek

Klin Onkol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The beneficial effect of probiotics in the prevention of irinotecan-induced diarrhea in colorectal cancer patients with colostomy: a pooled analysis of two probiotic trials (Probio-SK-003 and Probio-SK-005) led by Slovak Cooperative Oncology Group.
Michal Mego, Barbora Kasperova, Jozef Chovanec, Radoslav Danis, Maria Reckova, Branislav Bystricky

Front Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12 LGG in colorectal cancer patients.
Michal Mego, Radoslav Danis, Jozef Chovanec, Silvia Jurisova, Branislav Bystricky

Front Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal dose of silymarin for the management of drug‑induced liver injury in oncology.
Filip Kohutek, Branislav Bystricky

Mol Clin Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis